The AHA also called for the CMS to obtain approval from the National Quality Forum as well as pre-rulemaking review from the Measure Application Partnership.
The CMS proposed measures are initiation of osteoclast inhibitors for breast cancer patients with multiple myeloma or cancer metastasized to the bone, overuse of imaging for breast cancers with low risk of metastasizing and avoidable emergency department visits and admissions for outpatient chemotherapy patients.
More Articles on Quality:
Patient Safety Tool: Congestive Heart Failure Discharge Guide
5 Keys to Gain Buy-in to Quality, Safety Measures
Study: Hospitals’ Surgical Quality Differs for Cancer, Non-Cancer Patients
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
